Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
The Indian Journal of Medical Research|February 9, 2007
The role of allopurinol in experimental acute necrotizing pancreatitisA Turan Isik, M Refik Mas, Levent Yamanel, et al.Mediators of Inflammation|March 30, 2007
Soluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucoseIlker Tasci, Teoman Dogru, Alper Sonmez, et al.Cancer Research and Treatment|October 25, 2013
A rare presentation of follicular lymphoma: cerebellar involvement, successfully treated with a combination of radiotherapy and chemotherapyNuri Karadurmus, Selmin Ataergin, Gokhan Erdem, et al.Atherosclerosis|October 11, 2008
LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemiaIlker Tasci, Gokhan Erdem, Gokhan Ozgur, et al.Upsala Journal of Medical Sciences|May 17, 2008
Platelet aggregation is not enhanced in patients with prediabetesTeoman Dogru, Halil Genc, Ilker Tasci, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 17, 2009
Relationship between hemoglobin and CD40 ligand in prediabetesMustafa Kutlu, Alper Sonmez, Halil Genc, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2020
Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantationIsmail Erturk, Nuri Karadurmus, Halil Kızıloz, et al.Diabetes Research and Clinical Practice|September 8, 2006
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose toleranceTeoman Dogru, Alper Sonmez, Ilker Tasci, et al.Clinical Biochemistry|November 22, 2011
Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndromeHalil Genc, Teoman Dogru, Serkan Tapan, et al.Case Reports in Surgery|June 1, 2018
BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case ReportYasar Subutay Peker, Mehmet Fatih Can, Ismail Hakki Ozerhan, et al.Pageof 3